Researchers identify key mechanism behind atherosclerosis in Hutchinson-Gilford progeria syndrome

FHS
October 7, 2024
11:44 am

A team of researchers from the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), the Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC), and the Instituto de Ciencias de Materiales de Madrid (ICMM-CSIC) has made a significant breakthrough in understanding the underlying causes of cardiovascular disease in patients with Hutchinson-Gilford progeria syndrome (HGPS), an ultra-rare genetic disorder that accelerates the aging process.

Renaissance to in-license St Jude’s humanised antibody

Hu14.18 is in development for the treatment of newly diagnosed high-risk neuroblastoma. Credit: Kateryna Kon/Shutterstock.com. Renaissance Pharma has signed an agreement to in-license St Jude

August 1, 2023

Can crafted meal plans in kindergarten lead to healthier kids?

Crafted meal plans in kindergarten significantly boost children’s intake of vegetables, whole grains, and nuts, according to a study in the journal Nutrients. The research

September 25, 2023

California voters consider tough love for repeat drug offenders

California voters are considering whether to roll back some of the criminal justice reforms enacted a decade ago as concerns about mass incarceration give way

September 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.